Related Experiment Video
Updated: Apr 6, 2026
09:31
Analyzing Oxidative Stress in Murine Intestinal Organoids using Reactive Oxygen Species-Sensitive Fluorogenic Probe
Published on: September 17, 2021
4.9K
Oxygen sensing in intestinal mucosal inflammation
Katharina Flück1, Joachim Fandrey2
1Institut für Physiologie, Universität Duisburg-Essen, Essen, Germany.
Pflugers Archiv : European Journal of Physiology
|July 25, 2015
Summary
Hypoxia, or low oxygen, is key in inflammatory bowel disease (IBD) pathogenesis. Targeting the hypoxia-inducible factor (HIF) pathway offers therapeutic potential for IBD by modulating cellular adaptation to low oxygen conditions.
Area of Science:
- Gastroenterology
- Immunology
- Cellular Biology
Background:
- Hypoxia is prevalent in chronically inflamed tissues, particularly in inflammatory bowel disease (IBD).
- Intestinal barrier dysfunction and increased immune cell oxygen consumption exacerbate hypoxia in IBD.
- The hypoxia-inducible factor (HIF)-1 complex is crucial for cellular adaptation to low oxygen tension.
Purpose of the Study:
- To review the role of HIF-1α in intestinal mucosal inflammation.
- To explore the therapeutic potential of targeting the HIF pathway in IBD.
Main Methods:
- Review of existing literature on HIF-1α function in IBD.
- Analysis of cellular adaptation mechanisms to hypoxia in the intestinal mucosa.
- Examination of the role of HIF-1α in immune cells relevant to IBD pathogenesis.
Main Results:
- HIF-1α is a key transcription factor regulating cellular responses to hypoxia.
- Studies have investigated HIF-1α in intestinal epithelial cells and immune cells (T cells, dendritic cells).
- PHD inhibitors stabilize HIF-1, showing therapeutic effects in murine colitis models.
Conclusions:
- HIF-1α plays a critical role in the pathogenesis of IBD.
- Targeting the HIF pathway presents promising therapeutic strategies for managing intestinal mucosal inflammation.
